NCT01351805 2025-12-03
VITAL
Brigham and Women's Hospital
Phase NA Completed
Clinical Trials
12 trialsNCT02295059 2025-09-16
Omega 3 Fatty Acids and ERPR(-)HER2(+/-) Breast Cancer Prevention
City of Hope Medical Center
Phase NA Active not recruiting
NCT06928701 2025-04-15
NEOMET
University of Eastern Piedmont
Phase NA Recruiting
NCT04006847 2022-07-01
Omega -3 Fatty Acid in Combination With Tyrosine Kinase Inhibitors in Chronic Myeloid Leukemia
Milton S. Hershey Medical Center
Phase 1/2 Terminated
NCT03151291 2018-10-16
Effects of WB-EMS and Specific Dietary Supplements on Cancer Patients
University of Erlangen-Nürnberg Medical School
Phase NA Unknown
NCT01661764 2018-06-08
Fish Oil Supplementation, Nutrigenomics and Colorectal Cancer Prevention
Vanderbilt University Medical Center
Phase 2 Completed
NCT00815685 2017-03-23
A Pilot Study of Eicosapentaenoic Acid (EPA) in Patients With Cancer Cachexia
H. Lee Moffitt Cancer Center and Research Institute
Phase NA Completed
NCT02069561 2015-09-18
EPAUC
IRCCS Azienda Ospedaliero-Universitaria di Bologna
Phase NA Completed
NCT01048463 2011-10-06
Effect of Enteral Nutrition Rich in Eicosapentaenoic Acid (EPA) on Patients Receiving Chemotherapy for GI Tumor
Sun Yat-sen University
Phase 3 Unknown
NCT00432913 2008-10-17
Effect of 2 Doses of EPA on Apoptosis and Cell Proliferation on Colon Mucosa
S.L.A. Pharma AG
Phase 2/3 Completed
NCT00455416 2008-05-21
KLYMF
Oslo University Hospital
Phase 2 Unknown
NCT00168987 2008-05-09
Influence of an Oral Nutritional Supplement Rich in Omega-3 Fatty Acids on Functional State and Quality of Life in Malnourished Patients With Gastroenterological Tumors
Charite University, Berlin, Germany
Phase 4 Completed